Understanding risk factors for opioid overdose in clinical populations to inform treatment and policy

Journal of Addiction Medicine

Volumn 10, Issue 6, 2016, Pages 369-381

  Park, Tae Woo ^a   Lin, Lewei Allison ^b   Hosanagar, Avinash ^b,c   Kogowski, Amanda ^b   Paige, Katie ^b   Bohnert, Amy S B ^b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Clinical populations; Opioid analgesics; Overdose; Poisoning; Risk factors

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; NARCOTIC ANALGESIC AGENT; ZOLPIDEM;

CLINICAL PRACTICE; COMORBIDITY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG EFFECT; HEALTH CARE POLICY; HUMAN; INTOXICATION; PAIN; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT PLANNING; DRUG OVERDOSE;

ANALGESICS, OPIOID; DRUG OVERDOSE; HUMANS; PAIN;

EID: 85010064931     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000245     Document Type: Review

References (39)

1. Baumblatt JAG, Wiedeman C, Dunn JR, et al. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med 2014;174:796-801.
2. Becker WC, Fraenkel L, Kerns RD, et al. A research agenda for enhancing appropriate opioid prescribing in primary care. J Gen Intern Med 2013; 28:1364-1367.
3. Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011; 305:1315-1321.
4. Braden JB, Russo J, Fan MY, et al. Emergency department visits among recipients of chronic opioid therapy. JAMA Intern Med 2010;170: 1425-1432.
5. Bruehl S, Apkarian AV, Ballantyne JC, et al. Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. J Pain 2013;14:103-113.
6. Centers for Disease Control and Prevention.Web-based Injury Statistics Query and Reporting System (WISQARS) [CDC website]. Available at: http:// www.cdc.gov/injury/wisqars/fatal.html. Accessed September 8, 2015.
7. Chen LH, Hedegaard H, Warner M. Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011. NCHS data brief, no 166. Hyattsville, MD: National Center for Health Statistics; 2014.
8. Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med 2015;162:276-286.
9. Dart RC, Surratt HL, Cicero TJ, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med 2015;372:241-248.
10. Dasgupta N, Funk MJ, Proescholdbell S, et al. Cohort study of the impact of high-dose opioid analgesics on overdose mortality. Pain Med 2016;17: 85-98.
11. Dhalla IA, Mamdani MM, Gomes T, et al. Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario. Can Fam Physician 2011;57:e92-e96.
12. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain: United States. JAMA 2016;315:1624-1645.
13. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010;152:85-92.
14. Furlan AD, Sandoval JA, Mailis-Gagnon A, et al. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006;174:1589-1594.
15. Gomes T, Mamdani MM, Dhalla IA, et al. Opioid dose and drug-related mortality in patients with nonmalignant pain. JAMA Intern Med 2011;171:686-691.
16. Hartung DM, Middleton L, Haxby DG, et al. Rates of adverse events of longacting opioids in a state Medicaid program. Ann Pharmacother 2007; 41:921-928.
17. Huguet N, Kaplan MS, McFarland BH. Rates and correlates of undetermined deaths among African Americans: results from the National Violent Death Reporting System. Suicide Life Threat Behav 2012;42:185-196.
18. Im JJ, Shachter RD, Oliva EM, et al. Association of care practices with suicide attempts in US veterans prescribed opioid medications for chronic pain management. J Gen Intern Med 2015;30:979-991.
19. Kaplovitch E, Gomes T, Camacho X, et al. Sex differences in dose escalation and overdose death during chronic opioid therapy: a population-based cohort study. PLOS One 2015;10:e0134550.
20. King NB, Fraser V, Boikos C, et al. Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review. Am J Public Health 2014;104:e32-e42.
21. Lewis ET, Combs A, Trafton JA. Reasons for under-use of prescribed opioid medications by patients in pain. Pain Med 2010;11:861-871.
22. Liang Y, Turner BJ. Assessing risk for drug overdose in a national cohort: role for both daily and total opioid dose? J Pain 2015;16:318-325.
23. Miller M, Barber CW, Leatherman S, et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med 2015;175:608-615.
24. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010;1: CD006605.
25. Nuckols TK, Anderson L, Popescu I, et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med 2014;160:38-47.
26. Park TW, Saitz R, Ganoczy D, et al. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ 2015;350:h2698.
27. Paulozzi LJ. Prescription drug overdoses: a review. J Safety Res 2012;43:283-289.
28. Paulozzi LJ, Kilbourne EM, Shah NG, et al. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med 2012; 13:87-95.
29. Pletcher MJ, Kertesz SG, Kohn MA, et al. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA 2008;299:70-78.
30. Ray WA, Chung CP, Murray KT, et al. Out-of-hospital mortality among patients receiving methadone for noncancer pain. JAMA Intern Med 2015;175:420-427.
31. Starrels JL, Becker WC, Weiner MG, et al. Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med 2011;26:958-964.
32. Turk DC, Wilson HD, Cahana A. Treatment of chronic non-cancer pain. Lancet 2011;377:2226-2235.
33. Turner BJ, Liang Y. Drug overdose in a retrospective cohort with non-cancer pain treated with opioids, antidepressants, and/or sedative-hypnotics: interactions with mental health disorders. J Gen Intern Med 2015;30:1081-1096.
34. Wakeland W, Nielsen A, Geissert P. Dynamic model of nonmedical opioid use trajectories and potential policy interventions. Am J Drug Alcohol Abuse 2015;41:508-518.
35. WebsterLR,Cochella S,DasguptaN, et al.Ananalysis of the root causes for opioidrelated overdose deaths in the United States. Pain Med 2011;12:S26-S35.
36. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004;57:131-141.
37. Yang Z, Wilsey B, Bohm M, et al. Defining risk of prescription opioid overdose: pharmacy shopping and overlapping prescriptions among longterm opioid users in Medicaid. J Pain 2015;16:445-453.
38. Zedler B, Xie L, Wang L, et al. Risk factors for serious prescription opioidrelated toxicity or overdose among Veterans Health Administration patients. Pain Med 2014;15:1911-1929.
39. Zedler B, Xie L, Wang L, et al. Development of a risk index for serious prescription opioid-induced respiratory depression or overdose in Veterans' Health Administration patients. Pain Med 2015;16:1566-1579.